Skip to main content
The Journal of Biological Chemistry logoLink to The Journal of Biological Chemistry
. 2012 Jan 27;287(11):8652–8659. doi: 10.1074/jbc.M111.331280

Characterization and Purification of a Na+/Ca2+ Exchanger from an Archaebacterium*

Gabriel Mercado Besserer , Debora A Nicoll ‡,§, Jeff Abramson ‡,1, Kenneth D Philipson ‡,§,2
PMCID: PMC3318693  PMID: 22287543

Background: Databases include many putative prokaryotic Na+/Ca2+ exchangers, but none have been functionally expressed.

Results: A membrane protein (MaX1) of Methanosarcina acetivorans catalyzes electrogenic countertransport of Na+ and Ca2+.

Conclusion: MaX1 has properties similar to those of mammalian Na+/Ca2+ exchangers.

Significance: The characterization and purification of MaX1 should facilitate structure/function studies.

Keywords: Calcium, Calcium Transport, Exchangers, Sodium Calcium Exchange, Sodium Transport

Abstract

The superfamily of cation/Ca2+ exchangers includes both Na+/Ca2+ exchangers (NCXs) and Na+/Ca2+,K+ exchangers (NCKX) as the families characterized in most detail. These Ca2+ transporters have prominent physiological roles. For example, NCX and NCKX are important in regulation of cardiac contractility and visual processes, respectively. The superfamily also has a large number of members of the YrbG family expressed in prokaryotes. However, no members of this family have been functionally expressed, and their transport properties are unknown. We have expressed, purified, and characterized a member of the YrbG family, MaX1 from Methanosarcina acetivorans. MaX1 catalyzes Ca2+ uptake into membrane vesicles. The Ca2+ uptake requires intravesicular Na+ and is stimulated by an inside positive membrane potential. Despite very limited sequence similarity, MaX1 is a Na+/Ca2+ exchanger with kinetic properties similar to those of NCX. The availability of a prokaryotic Na+/Ca2+ exchanger should facilitate structural and mechanistic investigations.

Introduction

The Na+/Ca2+ exchangers are plasma membrane proteins that have important roles in maintaining Ca2+ homeostasis in nearly all types of animal cells (1). Na+/Ca2+ exchangers function as efficient electrogenic antiporters that extrude cytoplasmic Ca2+ against an electrochemical potential by utilizing the energy of the inwardly directed Na+ gradient. The two primary groups of Na+/Ca2+ exchangers are the K+-independent and K+-dependent Na+/Ca2+ exchangers (NCX3 and NCKX families, respectively). NCXs exchange 3 Na+ for 1 Ca2+ (although this stoichiometry is not absolute) (2), whereas NCKXs exchange 4 Na+ for 1 Ca2+ plus 1 K+. The Na+/Ca2+ exchangers are identified by regions known as α repeats (3), which define the superfamily. The α repeats (α-1 and α-2) are regions of intramolecular homology within the TMSs (see Fig. 1) that are important for transport function (4, 5), i.e. α repeats of members of the exchanger family demonstrate both inter- and intramolecular homology.

FIGURE 1.

FIGURE 1.

MaX1 protein. A, sequence and proposed TMSs (TM; double underlines) of MaX1. B, proposed secondary structure of MaX1. Note the opposite orientations of the homologous α repeats. The numbers inside each putative TMS indicate beginning and ending residues. C, ClustalW sequence alignment of the highly conserved α-1 and α-2 repeats of MaX1 with those from a putative E. coli NCX (YrbG) and from human NCKX1 and NCX1. Highly conserved amino acids are highlighted in gray, and two highly conserved and internally homologous regions are boxed.

Na+/Ca2+ exchange activity has critical roles in cardiac contractility, smooth muscle tone, renal Ca2+ reabsorption, photoreceptor signal transduction, and neural function. NCX1.1 of cardiac muscle is the Na+/Ca2+ exchanger that has been investigated in most detail. This includes functional, structural, and physiological studies (1, 6, 7). The Na+/Ca2+,K+ exchanger of rod photoreceptors, NCKX1, has also received much attention (8).

The animal NCX and NCKX proteins are members of a larger cation/Ca2+ exchanger superfamily (9), which consists of five discrete clade groups of structural homologs. The other groups of the superfamily include the insect and nematode cation/Ca2+ exchangers (CCX), the plant and fungi H+/Ca2+ exchangers (CAX), and the archaeal and eubacterial YrbG group (named after the gene of the homolog found in Escherichia coli), for which no known function for any member has been described. The YrbG homologs are of special interest, as prokaryotic membrane proteins have the potential of being more experimentally tractable than eukaryotic exchangers for many studies. There have been a few sporadic reports in the literature of prokaryotic Na+/Ca2+ exchange activity in membranes from a Halobacterium (10), an alkalophilic Bacillus (11), and Streptococcus pneumoniae (12). In no case, however, has the exchange activity been associated with a specific protein.

Current information from completely sequenced genomes of bacteria and archaea has revealed the existence of many YrbG-related genes with characteristic α repeats. We expressed several of these genes in E. coli. One of these genes from the archaeon Methanosarcina acetivorans expressed well and was amenable to purification and reconstitution. We report here the functional characterization of the M. acetivorans NCX homolog (MaX1), the first known prokaryotic Na+/Ca2+ exchanger protein.

EXPERIMENTAL PROCEDURES

Reagents

All reagents were of the highest purity available commercially. Valinomycin was from Sigma-Aldrich; DDM was from Anatrace; Taq polymerase and restriction enzymes were from New England Biolabs; and the protein ladder was from Fermentas. E. coli strains were obtained from Stratagene. Growth media were from VWR International. PCR primers were obtained from Integrated DNA Technologies.

Bacteria, Plasmids, and Growth Media

The LB plates contained Luria broth (13) plus 15 g/liter Bacto agar (VWR International). Terrific broth medium contained 12 g/liter Bacto-Tryptone (VWR International), 24 g/liter Bacto-yeast extract (VWR International), 4 ml/liter glycerol, 2.3 g/liter KH2PO4, and 12.5 g/liter K2HPO4. Kanamycin antibiotic (Sigma) was added to the media at 50 μg/ml. Cloning and propagation of DNA were done in E. coli XL1-Blue cells (Stratagene), and the E. coli C41(DE3) strain was used for expression of MaX1 (14).

Construction of MaX1-pWarf

The gene encoding MaX1 was amplified by PCR from purified M. acetivorans genomic DNA using oligomers GACACTCGAGATGATCACAGTGAATTTTCTCATTC and GAACGGATCCGATGTAGAATAAAACTACAAGG, designed from the Q8TPA6 genome sequence (UniProt). The isolated amplified product was cloned into the XhoI-BamHI sites of the pWarf(+) or pWarf(−) vectors (15) using standard restriction and ligation techniques. Constructs were verified by sequencing. Cloning MaX1 into pWarf vectors allows MaX1 to be fused at its C terminus to a HRV 3C protease tag followed by a GFP reporter fusion protein and a His8 tag, which allows for experimental manipulation. When cleaved with HRV 3C, MaX1 is liberated from the rest of the fusion tag, producing full-length MaX1 with a 6-amino acid overhang as described by Hsieh et al. (15). pWarf(+) has an additional sequence representing the TMS of GpA between the HRV 3C site and GFP. A MaX1-His construct was also prepared by mutating the HindIII site of pWarf(+) into a BamHI site, digesting the resulting construct with BamHI to excise the HRV 3C-GpA-GFP tag, and then re-ligating the construct.

Growth and Expression Conditions

MaX1 was expressed under optimized conditions as follows. 50 ml of LB medium in 250-ml baffled flasks was inoculated with freshly transformed C41(DE3) colonies carrying the MaX1-pWarf(+) construct or the empty pWarf(+) vector as a control and grown overnight at 37 °C and 225 rpm. 10 ml of the overnight cultures was diluted into 1 liter of Terrific broth medium in 4-liter baffled flasks and incubated at 37 °C and 225 rpm until the absorbance at 600 nm reached 0.8. At this point, the temperature was lowered to 25 °C, and fusion protein expression was induced for 6 h with 1 mm isopropyl β-d-thiogalactopyranoside. Cells were then harvested by low speed centrifugation and stored at −20 °C.

Isolation of Inside-out Membrane Vesicles

Cells were harvested at 5500 rpm for 10 min at 4 °C and washed with 50 mm potassium Pi (pH 7.5). ISO bacterial membrane vesicles were prepared using the methodology of Nagamori et al. (16). The final ISO vesicle pellet was resuspended in 50 mm potassium Pi and 1 mm EDTA, homogenized, and flash-frozen to −80 °C for storage. The protein concentration was determined by the BCA protein assay (Pierce). The presence of MaX1 in the ISO vesicles was verified by Western blotting using HRP-conjugated anti-pentahistidine antibody (Qiagen) and visualized by a horseradish peroxidase reaction and in-gel GFP fluorescence (17).

Detergent Solubilization and Purification

Cell pellets containing the overexpressed MaX1-GFP fusion protein were resuspended in 5 ml of lysis buffer (50 mm Tris (pH 7.5), 150 mm NaCl, 0.04 mg/ml DNase, and 0.1 mm PMSF) per g of cells and disrupted using an EmulsiFlex C3 system (ATA Scientific). Cell debris was removed by low speed centrifugation at 10,000 × g for 20 min, and membranes were isolated by ultracentrifugation at 302,000 × g for 1 h. All steps were performed at 4 °C.

Membranes were solubilized in 50 mm Tris (pH 8), 150 mm NaCl, 20 mm imidazole, and 2% DDM at 4 °C with continuous stirring for 1 h. Membrane debris was cleared by centrifugation at 53,000 × g for 1 h. Solubilized MaX1-GFP from the supernatant was then purified to homogeneity by immobilized metal ion affinity chromatography using a nickel-nitrilotriacetic acid Superflow resin column (Qiagen). The column was washed with 50 mm Tris (pH 8), 150 mm NaCl, 25 mm imidazole, and 0.017% DDM for 20 column volumes and eluted in a linear gradient from 25 to 500 mm imidazole over 10 column volumes at a flow rate of 1.0 ml/min.

Eluted fractions were concentrated and washed with 50 mm Tris (pH 7.5) and 50 mm NaCl using 100-kDa Amicon concentrators with centrifugation at 12,000 × g for 30 min. Enriched MaX1 proteins were adjusted to 10 mg/ml in 50 mm Tris (pH 7.5), 50 mm NaCl, 0.017% DDM, and 50% glycerol buffer and stored at −80 °C.

Samples were examined on SDS-9% polyacrylamide gels stained with Coomassie Blue, and protein concentration was determined at A280 using extinction coefficients of 50,895 m−1 cm−1 for MaX1-GpA-GFP-His and 28,880 m−1 cm−1 for MaX1-His (ProtParam).

Activity Assays

Frozen ISO bacterial vesicles were resuspended in a 100-fold excess volume of 140 mm NaCl and 10 mm MOPS/Tris (pH 7.4) and incubated at 4 °C for 1 h. Vesicles were then recovered by ultracentrifugation at 140,000 × g for 90 min. Pellets were resuspended in 140 mm NaCl and 10 mm MOPS/Tris (pH 7.4) to a final concentration of 5 mg/ml total protein and incubated at 4 °C for at least 4 h. In some cases, we used KCl, LiCl, or choline chloride as a substitute for NaCl to prepare vesicles loaded with ions other than Na+.

Na+ gradient-dependent 45Ca2+ uptake was measured as described in detail previously (18). Typically, 5 μl of NaCl (140 mm)-loaded E. coli vesicles was rapidly added to 245 μl of Ca2+ uptake medium containing 140 mm choline chloride, 10 mm MOPS/Tris (pH 7.4), 10 μm CaCl2, and 6 μCi/ml 45CaCl2 at 37 °C. Variations of this protocol are noted below.

The Ca2+ uptake reaction was stopped after 5 s by the automated addition of 30 μl of 140 mm KCl and 10 mm EGTA. Immediately thereafter, 1 ml of ice-cold 140 mm KCl and 1 mm EGTA was added. 1 ml of this solution was applied to a 0.45-μm Millipore nitrocellulose filter under suction. The filter was washed with two 3-ml aliquots of ice-cold 140 mm KCl and 1 mm EGTA. Radioactive Ca2+ on the filters was quantified by liquid scintillation counting. Data are shown as means ± S.E.

RESULTS AND DISCUSSION

Prokaryotic YrbG Homologs

We cloned 12 YrbG homologs using PCR products from genomic DNA. The clones were inserted into both pWarf(+) and pWarf(−) expression vectors (15) and expressed in E. coli. In initial studies, we found that the YrbG homolog from the archaeon M. acetivorans (MaX1) expressed well, displayed functional activity, and could be purified. We chose to concentrate on MaX1 (UniProt Q8TPA6) for initial characterization of a member of the YrbG family.

MaX1 Sequence Analysis

The MaX1 open reading frame is 1050 bp and encodes a protein of 350 amino acids with a calculated molecular mass of 38 kDa. Hydropathy analysis predicted that MaX1 contains 10 TMSs (Fig. 1, A and B) arranged in two groups of five TMSs separated by a hydrophilic intracellular domain of ∼63 amino acids. To model the potential TMSs (Fig. 1A), we utilized the results predicted by the TMpred program with the standard prediction parameters for a transmembrane helix length of between 12 and 33 residues, similarities between the two halves of MaX1 (see below), and similarities to NCX1 (19, 20) and YrbG (21), for which TMSs have been experimentally determined. NCX1 has nine TMSs, but like YrbG, MaX1 is predicted to have an additional TMS in the C-terminal half of the protein that places the C terminus at the extracellular surface. The “inside positive” rule (22), that arginine and lysine residues are more prevalent in loops connecting TMSs at the intracellular surface than in extracellular loops, is obeyed in this model for MaX1.

MaX1 contains α repeats (Fig. 1, B and C), the defining characteristic of Na+/Ca2+ exchangers. These regions span TMS2 and TMS3 (α-1) and TMS7 and TMS8 (α-2) and, for MaX1, are 50% identical (compared with 24% identity between the NCX1 α repeats). For MaX1, as for the putative E. coli exchanger YrbG (21), the identities between the two halves of the proteins is striking and is further evidence that the exchanger proteins arose from a gene duplication event. That the α repeats are the only part of this gene duplication event still in evidence in the mammalian exchangers strongly suggests the functional importance of these regions and is consistent with mutational analysis (4, 5). In Fig. 1C, the MaX1 α repeats are aligned with those from NCX1, NCKX1, and YrbG. MaX1 α-1 is 31% and α-2 is 40% identical to their human NCX1 counterparts. Each of the α repeats maintains the conserved motif G(T/S)SXP(E/D)X21–24GSX3N, which has been implicated in ion transport in NCX1. For example, Asp-54 (α-1 region) and Glu-256 (α-2 region) of MaX1 are homologous to Glu-113 and Asp-814 of NCX1.1. Conservative mutations of Glu-113 and Asp-814 completely inactivate NCX1.1 (5). The α repeats are present on opposite sides of the membrane and likely form an inverted repeat motif, as seen in Na+ symporters (23).

Like the NCXs, MaX1 has a hydrophilic domain between TMS5 and TMS6 that is modeled to be intracellular. However, in MaX1, this domain is small, only 63 amino acids, with 10 acidic and 11 basic amino acids and a calculated pI of 7. The hydrophilic domain contains neither the exchanger inhibitory peptide (24) nor Ca2+ regulatory domains (25, 26) that have been identified in NCXs. A BLASTp search with the hydrophilic domain revealed similarities only to other bacterial members of the NCX superfamily. Thus, there is no evidence that this domain is involved in any specific regulatory role, as it is in the mammalian NCXs.

M. acetivorans has two additional genes with high similarity to MaX1 that we designate MaX2 (GenBankTM accession number NP617716.1) and MaX3 (NP617914.1). MaX1 and MaX2 have an identity of 47%. MaX3 is more divergent, with 29 and 28% identities to MaX1 and MaX2, respectively. The identities are primarily restricted to the TMSs. The hydrophilic domains between TMS5 and TMS6 of the MaX proteins are quite different, and the MaX2 domain is curiously enriched in glutamate, lysine, and isoleucine (22, 15, and 15%, respectively). Because, in NCX1, the TMSs are important in ion transport and the hydrophilic domain is important in regulation, the sequences suggest that the MaX proteins share similar transport properties but different regulatory properties or expression profiles.

Expression and Purification

GFP fluorescence is a useful tool to monitor protein expression and purification, but, if the C terminus of a membrane protein is extracellular, GFP fluorescence is not detected. The pWarf(+) and pWarf(−) expression vectors both fuse a HRV 3C protease site followed by GFP and a His8 tag to the C terminus of the expressed protein. In addition, there is a sequence representing the TMS of GpA between the HRV 3C site and GFP in pWarf(+).The presence of the additional TMS creates an internal C terminus for those membrane proteins with endogenous external C termini. Expression of MaX1 showed a membrane-associated accumulation of GFP fluorescence only when expressed with pWarf(+) (data not shown), indicating that the C terminus of MaX1 is extracellular. The vector system is described in detail in Ref. 15.

Tagged MaX1 was purified using a nickel affinity column (Fig. 2, A and B), with a recovery of ∼33% and a final yield of ∼1 mg/liter of culture medium. The apparent molecular mass of tagged MaX1 is 43 kDa. The higher molecular mass bands may be at least partially due to oligomerization, as they show some signal by in-gel GFP fluorescence. The identity of the protein was verified by confirming the presence of GFP by in-gel fluorescence and mass spectrometry (data not shown). We were also able to isolate a MaX1-His protein lacking the other tags, as shown in Fig. 2.

FIGURE 2.

FIGURE 2.

SDS-PAGE analysis of MaX1-GpA-GFP-His8 and MaX1-His8 fusion proteins. A, overexpressed MaX1-GpA-GFP-His8 (lane 1) and MaX1-His8 (lane 2) fusion proteins were purified with a nickel affinity column from DDM-solubilized E. coli (C41(DE3)) membranes, analyzed by 9% SDS-PAGE, and visualized with Coomassie Brilliant Blue R-250. Arrows indicate the positions of MaX1-GpA-GFP-His and MaX1-His8 fusion proteins. B, the identity of MaX1-GpA-GFP-His8 protein in ISO vesicles (lane 1) was confirmed by 9% SDS-PAGE in-gel GFP fluorescence by comparison with ISO vesicles containing overexpressed MaX1-His8 (lane 2) or purified MaX1-GpA-GFP-His8 (lane 3) and MaX1-His8 (lane 4) proteins. 5 μg of protein was loaded per lane. See “Experimental Procedures” for further details.

MaX1 Catalyzes Na+ Gradient-dependent Ca2+ Uptake

In most experiments, we used ISO membrane vesicles from E. coli expressing MaX1 tagged (HRV 3C protease site, GpA, GFP, and His tag) at the C terminus. For simplicity, we will refer to this protein as MaX1. Control experiments will be described below to demonstrate that it is unlikely that the presence of these tags, including the additional TMS provided by the GpA, altered transport properties.

To test the possibility that MaX1 functions as a Na+/Ca2+ exchanger, we measured Na+ gradient-dependent 45Ca2+ uptake into membrane vesicles. Briefly, Na+-loaded vesicles were diluted into Na+-free medium containing 45Ca2+ to activate Ca2+ uptake. This assay has been utilized extensively to investigate mammalian Na+/Ca2+ exchangers (18). Fig. 3 shows the time course of Ca2+ uptake into vesicles diluted in choline chloride medium. Several experiments demonstrated that Ca2+ uptake was linear for ∼10 s. In experiments below, uptake was carried out for 5 s as a measure of the initial rate. Ca2+ uptake was maximal at ∼1 min and then declined over several minutes to a low level. This time course is important because it demonstrates that Ca2+ is accumulating against a concentration gradient and is not merely passively equilibrating across the membrane. Thus, the Ca2+ uptake must be driven by an energy source (presumably the Na+ gradient). After the Na+ gradient dissipates, accumulated Ca2+ leaks out of the vesicles and eventually reaches an equilibrium value. Uptake varied with preparation but was always within the range of 70–90 pmol of Ca2+/mg of protein/s when Ca2+ was 10 μm.

FIGURE 3.

FIGURE 3.

Time course of Ca2+ uptake mediated by MaX1. NaCl (140 mm)-loaded membrane vesicles from E. coli expressing MaX1 protein were diluted 50-fold into reaction medium containing choline chloride plus 10 μm 45Ca2+ and incubated at 37 °C. Aliquots of 250 μl were removed at the indicated times, and 45Ca2+ uptake was stopped by the addition of 1 ml of cold 140 mm KCl and 1 mm EGTA. Assays were performed in duplicate using three different vesicle preparations. Shown is a representative experiment.

In some initial experiments, we used membrane vesicles isolated from E. coli expressing MaX1 with only a His tag at the C terminus (MaX1-His). This is the case for the results shown in Fig. 4A. To begin characterization of MaX1 function, we measured 45Ca2+ uptake into MaX1-His membrane vesicles under different ionic conditions (Fig. 4A, left). Ca2+ uptake required the presence of an outwardly directed Na+ gradient. K+-loaded (or choline-loaded (data not shown)) vesicles did not facilitate substantial uptake of Ca2+. Intravesicular Na+ catalyzed Ca2+ uptake only if extravesicular Na+ was absent. Extravesicular Na+ inhibited Ca2+ uptake presumably by competing with Ca2+ for binding to transport sites. These properties are characteristic of Na+/Ca2+ exchangers (1). These experiments were repeated using membrane vesicles from E. coli not induced to express MaX1 (Fig. 4A, right). The E. coli vesicles not expressing MaX1 did not display significant Ca2+ uptake under any ionic conditions. Thus, if E. coli expresses a native Na+/Ca2+ exchanger, the level is below that needed for detection in this Ca2+ transport assay.

FIGURE 4.

FIGURE 4.

Ionic requirements for Ca2+ uptake mediated by MaX1. A, membrane vesicles from E. coli expressing MaX1-His protein (left) or control vesicles (right) with intravesicular NaCl or KCl (140 mm) were diluted 50-fold into reaction medium containing either choline chloride or NaCl (140 mm) plus 10 μm 45Ca2+. Ca2+ uptake was stopped after 5 s. See “Experimental Procedures” for more details. B, identical experiments using membrane vesicles expressing the fully tagged MaX1 protein. Assays were performed in duplicate using three different vesicle preparations. Data were normalized to control uptake conditions.

These experiments were repeated using fully tagged MaX1 (Fig. 4B). The results were essentially identical to those obtained using MaX1-His (Fig. 4A). Although we would have preferred to do all functional studies using native untagged MaX1, this proved to be difficult. First, MaX1-His with only one tag instead of four labels (HRV 3C, GpA, GFP, and His) did not express reproducibly well. Therefore, we performed only some initial experiments with this protein (see Fig. 4A and select experiments below). In all tested cases, the results were identical between MaX1-His and fully tagged MaX1. This suggests that the tags were not altering transport properties. Second, we attempted to remove tags from fully tagged MaX1 using HRV 3C protease. However, we found that the cleavage reaction was quite inefficient and thus not practical.

The experiments presented in Fig. 4 demonstrate that the Ca2+ uptake facilitated by MaX1 specifically required intravesicular Na+ and the absence of extravesicular Na+. These characteristics further support the contention that MaX1 is a Na+/Ca2+ exchanger. In single experiments, we found that like K+, intravesicular choline did not catalyze Ca2+ uptake, whereas internal Li+ induced Ca2+ uptake that was slightly higher than that which occurred with internal K+.

Ca2+ and Na+ Dependences

We measured Na+ gradient-dependent Ca2+ influx as a function of extravesicular Ca2+ concentration. Ca2+ uptake showed a saturable hyperbolic dependence on Ca2+, with a Kapp of 41.1 ± 2.0 μm (Fig. 5A). Saturation is most consistent with transporter-mediated Ca2+ uptake rather than a channel-mediated mechanism. This is a relatively low Ca2+ affinity and similar to that displayed by NCX1, which displays an apparent Ca2+ affinity of 20–40 μm (27, 28).

FIGURE 5.

FIGURE 5.

Na+ and Ca2+ concentration dependences for MaX1. A, Na+ gradient-dependent Ca2+ uptake as a function of extravesicular Ca2+ concentration. B, inhibition of Ca2+ uptake by extravesicular Na+. The Ca2+ concentration was 10 μm. All uptakes were terminated after 5 s. Data points are the average of three separate determinations. Data were fit to a single-binding site hyperbolic model (A) or to an inverse rectangular hyperbolic model (B).

We also measured the ability of extravesicular Na+ to compete with Ca2+ for binding to the ion-binding sites. At a constant Ca2+ concentration (10 μm), we varied the extravesicular Na+ concentration. As shown in Fig. 5B, external Na+ was a potent inhibitor of Ca2+ uptake (K0.5 = 2.9 ± 0.4 mm). In contrast, the K0.5 for inhibition of cardiac NCX1 by Na+ at a Ca2+ concentration of 8.6 μm was 12.6 mm (28). The ability of Na+ to inhibit Ca2+ uptake by MaX1 is consistent with the relatively low apparent affinity of MaX1 for Ca2+, enabling potent competition. We have not determined that direct competition is responsible for all of the effects of extravesicular Na+, i.e. we did not examine Na+ inhibitory potency at other Ca2+ concentrations. However, competitive effects are likely to be dominant for a Na+/Ca2+ exchanger. This assertion is supported by studies with other Na+/Ca2+ exchangers (28). We used fully tagged MaX1 to obtain these results. However, a nearly identical result was obtained using MaX1-His (K0.5 = 2.2 mm, n = 1).

Na+/Ca2+ Exchange Mediated by MaX1 Is Electrogenic

The NCX transporters exchange 3 Na+ for each Ca2+ (29), although a 4:1 stoichiometry has also been reported (30). Thus, the NCXs are electrogenic, with a net movement of positive charge in the same direction as Na+ translocation. For NCX1, the electrogenicity is readily demonstrated by using the K+ ionophore valinomycin to control membrane potential (31). In the absence of valinomycin, the rapid buildup of a negative-inside membrane potential inhibits vesicular Na+ gradient-dependent Ca2+ uptake. Extravesicular K+/valinomycin prevents the accumulation of intravesicular negative charge and relieves inhibition. To test the effects of membrane potential on MaX1, we measured Ca2+ uptake in KCl (140 mm; rather than choline chloride) uptake medium in the presence and absence of valinomycin. Valinomycin stimulated uptake by 60 ± 20% (Fig. 6). The data indicate that MaX1 catalyzes transport with a likely stoichiometry of 3 or more Na+ for each Ca2+. Valinomycin induced a similar level of stimulation of Ca2+ uptake in vesicles expressing MaX1-His (n = 1) (data not shown).

FIGURE 6.

FIGURE 6.

Effects of membrane potential on MaX1-catalyzed Ca2+ influx. Na+-loaded MaX1 vesicles were diluted into KCl reaction medium in the presence or absence of valinomycin (0.4 μm). Ca2+ (10 μm) uptake was stopped after 5 s. Data points are the average of four separate experiments (p < 0.03).

MaX1 could function as a member of the NCKX family, which exchanges 4 Na+ for 1 Ca2+ plus 1 K+. However, under no circumstances did we observe K+ stimulation of Na+/Ca2+ exchange activity. Robust Ca2+ uptake occurred in the complete absence of K+. In fact, uptake from high K+ medium was lower than that from choline medium (see Fig. 7 below).

FIGURE 7.

FIGURE 7.

Inhibition of MaX1-mediated Ca2+ uptake by mono-, di-, and trivalent cations. Ca2+ uptake was initiated by diluting Na+-loaded MaX1 vesicles into Ca2+ uptake medium containing 140 mm choline chloride, KCl, or LiCl as indicated. When present, the concentrations of MgCl2, MnCl2, and LaCl3 were 5 mm, 1 mm, and 10 μm, respectively. Results are shown as normalized Ca2+ uptake (n = 3). Error bars represent S.E.

Cation Inhibition of MaX1 Na+/Ca2+ Exchange

We tested the effects of various cations in the uptake medium on MaX1 Na+/Ca2+ exchange activity at 10 μm Ca2+ (Fig. 7). Replacement of choline with equimolar Na+ eliminated Ca2+ uptake, as also seen above (Figs. 4 and 5B). Replacement of choline with K+ or Li+ reduced Ca2+ uptake by 58 and 80%, respectively. Li+ can substitute for Na+ on some transporters such as the mammalian Na+/H+ exchanger (32) or the mitochondrial Na+/Ca2+ exchanger (33). Cardiac NCX1 does not transport Li+, although a mutant with altered ion selectivity has been reported to do so (34). Like extravesicular Na+, Li+ may compete with Ca2+ for transport sites to decrease Ca2+ uptake. Possibly, Li+ is actually transported by MaX1, and Li+/Ca2+ exchange is facilitated. We have not directly tested this possibility.

We next examined inhibition of MaX1 by two divalent cations. At 10 μm Ca2+, Mg2+ (5 mm) and Mn2+ (1 mm) inhibited Ca2+ uptake by 20 ± 7 and 67 ± 2%, respectively. This is somewhat less inhibition than the effects of Mg2+ and Mn2+ on Ca2+ uptake mediated by the cardiac Na+/Ca2+ exchanger (35). The trivalent ion La3+ has a similar ionic radius to Ca2+ and is often a potent inhibitor of Ca2+-activated events. We found that 10 μm La3+ inhibited MaX1 Ca2+ uptake by 79 ± 1%. In contrast, La3+ inhibited the cardiac sarcolemmal Na+/Ca2+ exchanger with a substantially higher potency. For example, at twice the Ca2+ concentration used here, NCX1 was inhibited by almost 100% at 10 μm La3+ (35). This suggests that MaX1 and NCX1 do not have identical Ca2+-binding sites.

Conclusions

We describe, for the first time, the functional activity of a member of the YrbG family of the cation/Ca2+ exchanger superfamily. We found that MaX1 of M. acetivorans is an electrogenic Na+/Ca2+ exchanger with properties most similar to those of mammalian NCX proteins. The similarity is perhaps surprising because homology of NCX and YrbG members is limited to the α repeat motifs. MaX1 is characterized as a Na+/Ca2+ exchanger, as it is able to actively accumulate Ca2+ in the presence of a supporting Na+ gradient. Other ions or energy sources do not seem to have a role in this process. The identification of a prokaryotic Na+/Ca2+ exchanger should provide opportunities for additional structural and functional studies.

Acknowledgments

We thank Jennifer Hsieh and Cheryl Yashar for technical assistance and the UCLA-DOE Protein Expression Core for providing genomic DNA for M. acetivorans.

*

This work was supported, in whole or in part, by National Institutes of Health Grants R01 HL49101 (to K. D. P.) and R21 HL093278 (to J. A.).

3
The abbreviations used are:
NCX
Na+/Ca2+ exchanger
NCKX
Na+/Ca2+,K+ exchanger
TMS
transmembrane segment
DDM
n-dodecyl-β-d-maltoside
HRV
human rhinovirus
GpA
glycophorin A
ISO
inside-out
PMSF
phenylmethylsulfonyl fluoride.

REFERENCES

  • 1. Philipson K. D., Nicoll D. A. (2000) Sodium/calcium exchange: a molecular perspective. Annu. Rev. Physiol. 62, 111–133 [DOI] [PubMed] [Google Scholar]
  • 2. Kang T. M., Hilgemann D. W. (2004) Multiple transport modes of the cardiac Na+/Ca2+ exchanger. Nature 427, 544–548 [DOI] [PubMed] [Google Scholar]
  • 3. Schwarz E. M., Benzer S. (1997) Calx, a Na+/Ca2+ exchanger gene of Drosophila melanogaster. Proc. Natl. Acad. Sci. U.S.A. 94, 10249–10254 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4. Ottolia M., Nicoll D. A., Philipson K. D. (2005) Mutational analysis of the α-1 repeat of the cardiac Na+/Ca2+ exchanger. J. Biol. Chem. 280, 1061–1069 [DOI] [PubMed] [Google Scholar]
  • 5. Nicoll D. A., Hryshko L. V., Matsuoka S., Frank J. S., Philipson K. D. (1996) Mutation of amino acid residues in the putative transmembrane segments of the cardiac sarcolemmal Na+/Ca2+ exchanger. J. Biol. Chem. 271, 13385–13391 [DOI] [PubMed] [Google Scholar]
  • 6. Shigekawa M., Iwamoto T. (2001) Cardiac Na+/Ca2+ exchange: molecular and pharmacological aspects. Circ. Res. 88, 864–876 [DOI] [PubMed] [Google Scholar]
  • 7. Lytton J. (2007) Na+/Ca2+ exchangers: three mammalian gene families control Ca2+ transport. Biochem. J. 406, 365–382 [DOI] [PubMed] [Google Scholar]
  • 8. Visser F., Lytton J. (2007) K+-dependent Na+/Ca2+ exchangers: key contributors to Ca2+ signaling. Physiology 22, 185–192 [DOI] [PubMed] [Google Scholar]
  • 9. Cai X., Lytton J. (2004) The cation/Ca2+ exchanger superfamily: phylogenetic analysis and structural implications. Mol. Biol. Evol. 21, 1692–1703 [DOI] [PubMed] [Google Scholar]
  • 10. Belliveau J. W., Lanyi J. K. (1978) Calcium transport in Halobacterium halobium envelope vesicles. Arch. Biochem. Biophys. 186, 98–105 [DOI] [PubMed] [Google Scholar]
  • 11. Ando A., Yabuki M., Kusaka I. (1981) Na+-driven Ca2+ transport in alkalophilic Bacillus. Biochim. Biophys. Acta 640, 179–184 [DOI] [PubMed] [Google Scholar]
  • 12. Trombe M. C. (1993) Characterization of a calcium porter of Streptococcus pneumoniae involved in calcium regulation of growth and competence. J. Gen. Microbiol. 139, 433–439 [DOI] [PubMed] [Google Scholar]
  • 13. Miller J. H. (1972) Experiments in Molecular Genetics, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY [Google Scholar]
  • 14. Miroux B., Walker J. E. (1996) Overproduction of proteins in Escherichia coli: mutant hosts that allow synthesis of some membrane proteins and globular proteins at high levels. J. Mol. Biol. 260, 289–298 [DOI] [PubMed] [Google Scholar]
  • 15. Hsieh J. M., Besserer G. M., Madej M. G., Bui H. Q., Kwon S., Abramson J. (2010) Bridging the gap: a GFP-based strategy for overexpression and purification of membrane proteins with intra- and extracellular C termini. Protein Sci. 19, 868–880 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16. Nagamori S., Vázquez-Ibar J. L., Weinglass A. B., Kaback H. R. (2003) In vitro synthesis of lactose permease to probe the mechanism of membrane insertion and folding. J. Biol. Chem. 278, 14820–14826 [DOI] [PubMed] [Google Scholar]
  • 17. Drew D., Lerch M., Kunji E., Slotboom D. J., de Gier J. W. (2006) Optimization of membrane protein overexpression and purification using GFP fusions. Nat. Methods 3, 303–313 [DOI] [PubMed] [Google Scholar]
  • 18. Vemuri R., Philipson K. D. (1988) Phospholipid composition modulates the Na+/Ca2+ exchange activity of cardiac sarcolemma in reconstituted vesicles. Biochim. Biophys. Acta 937, 258–268 [DOI] [PubMed] [Google Scholar]
  • 19. Nicoll D. A., Ottolia M., Lu L., Lu Y., Philipson K. D. (1999) A new topological model of the cardiac sarcolemmal Na+/Ca2+ exchanger. J. Biol. Chem. 274, 910–917 [DOI] [PubMed] [Google Scholar]
  • 20. Iwamoto T., Nakamura T. Y., Pan Y., Uehara A., Imanaga I., Shigekawa M. (1999) Unique topology of the internal repeats in the cardiac Na+/Ca2+ exchanger. FEBS Lett. 446, 264–268 [DOI] [PubMed] [Google Scholar]
  • 21. Sääf A., Baars L., von Heijne G. (2001) The internal repeats in the Na+/Ca2+ exchanger-related Escherichia coli protein YrbG have opposite membrane topologies. J. Biol. Chem. 276, 18905–18907 [DOI] [PubMed] [Google Scholar]
  • 22. von Heijne G., Gavel Y. (1988) Topogenic signals in integral membrane proteins. Eur. J. Biochem. 174, 671–678 [DOI] [PubMed] [Google Scholar]
  • 23. Abramson J., Wright E. M. (2009) Structure and function of Na+ symporters with inverted repeats. Curr. Opin. Struct. Biol. 19, 425–432 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24. Li Z., Nicoll D. A., Collins A., Hilgemann D. W., Filoteo A. G., Penniston J. T., Weiss J. N., Tomich J. M., Philipson K. D. (1991) Identification of a peptide inhibitor of the cardiac sarcolemmal Na+/Ca2+ exchanger. J. Biol. Chem. 266, 1014–1020 [PubMed] [Google Scholar]
  • 25. Matsuoka S., Nicoll D. A., Reilly R. F., Hilgemann D. W., Philipson K. D. (1993) Initial localization of regulatory regions of the cardiac sarcolemmal Na+/Ca2+ exchanger. Proc. Natl. Acad. Sci. U.S.A. 90, 3870–3874 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26. Hilge M., Aelen J., Vuister G. W. (2006) Ca2+ regulation in the Na+/Ca2+ exchanger involves two markedly different Ca2+ sensors. Mol. Cell 22, 15–25 [DOI] [PubMed] [Google Scholar]
  • 27. Bers D. M., Philipson K. D., Nishimoto A. Y. (1980) Sodium/calcium exchange and sidedness of isolated cardiac sarcolemmal vesicles. Biochim. Biophys. Acta 601, 358–371 [DOI] [PubMed] [Google Scholar]
  • 28. Reeves J. P., Sutko J. L. (1983) Competitive interactions of sodium and calcium with the sodium/calcium exchange system of cardiac sarcolemmal vesicles. J. Biol. Chem. 258, 3178–3182 [PubMed] [Google Scholar]
  • 29. Reeves J. P., Hale C. C. (1984) The stoichiometry of the cardiac sodium/calcium exchange system. J. Biol. Chem. 259, 7733–7739 [PubMed] [Google Scholar]
  • 30. Dong H., Dunn J., Lytton J. (2002) Stoichiometry of the cardiac Na+/Ca2+ exchanger NCX1.1 measured in transfected HEK cells. Biophys. J. 82, 1943–1952 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31. Philipson K. D., Nishimoto A. Y. (1980) Na+/Ca2+ exchange is affected by membrane potential in cardiac sarcolemmal vesicles. J. Biol. Chem. 255, 6880–6882 [PubMed] [Google Scholar]
  • 32. Hayashi H., Szászi K., Coady-Osberg N., Furuya W., Bretscher A. P., Orlowski J., Grinstein S. (2004) Inhibition and redistribution of NHE3, the apical Na+/H+ exchanger, by Clostridium difficile toxin B. J. Gen. Physiol. 123, 491–504 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33. Palty R., Silverman W. F., Hershfinkel M., Caporale T., Sensi S. L., Parnis J., Nolte C., Fishman D., Shoshan-Barmatz V., Herrmann S., Khananshvili D., Sekler I. (2010) NCLX is an essential component of mitochondrial Na+/Ca2+ exchange. Proc. Natl. Acad. Sci. U.S.A. 107, 436–441 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34. Doering A. E., Nicoll D. A., Lu Y., Lu L., Weiss J. N., Philipson K. D. (1998) Topology of a functionally important region of the cardiac Na+/Ca2+ exchanger. J. Biol. Chem. 273, 778–783 [DOI] [PubMed] [Google Scholar]
  • 35. Trosper T. L., Philipson K. D. (1983) Effects of divalent and trivalent cations on Na+/Ca2+ exchange in cardiac sarcolemmal vesicles. Biochim. Biophys. Acta 731, 63–68 [DOI] [PubMed] [Google Scholar]

Articles from The Journal of Biological Chemistry are provided here courtesy of American Society for Biochemistry and Molecular Biology

RESOURCES